SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-010978
Filing Date
2023-03-30
Accepted
2023-03-30 16:32:02
Documents
14
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-20230330.htm   iXBRL 8-K 56535
2 EX-99.1 stro-ex99_1.htm EX-99 260403
3 GRAPHIC img217863751_0.jpg GRAPHIC 5459
  Complete submission text file 0000950170-23-010978.txt   460057

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230330.xsd EX-101.SCH 2474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230330_lab.xml EX-101.LAB 13474
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230330_pre.xml EX-101.PRE 11060
8 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230330_htm.xml XML 4752
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 23781152
SIC: 2836 Biological Products, (No Diagnostic Substances)